Case studies Modules Legal Issues Diagnosis Anatomy& Physiology MCQs Visual Library |
|||||||||||||||
Case Studies Archive |
|||||||||||||||
| Users are encouraged to submit their views about
published papers through the feedback section. Nurse-prescriber would also welcome submission of case studies for publication within this section. Please send your contributions or ideas through the feedback section. Scenario Floella George, is a 60-year-old lady. She is worried about being constipated and has been taking medication, Co-danthramer, that has been prescribed for her husband who is terminally ill. She asks if you will prescribe this for her. Comment Accountability Writing a prescription implies an acceptance by the nurse prescriber of personal accountability for knowledge of the patients current and past medical history, current medications, and knowledge of the side effects and contraindications for the products prescribed. Therefore, the nurse has a responsibility to:
Safe & effective prescribing As part of an ongoing assessment process, Floella, needs to be asked the following to determine whether there is a real constipation problem:
Drug induced constipation, or constipation as a result of insufficient fluid intake must be identified. Sickness, nausea or abdominal pain raise suspicions of pathology and the patient should be referred to their GP (Derrett 2001). Patients with any of the following symptoms need to be referred to their GP:
Abdominal pain/tenderness. Constipation can frequently be treated successfully with non-pharmalogical methods and this should be the first step in the management of this problem. An increase in dietary fibre and fluid intake, where appropriate, should be considered and implemented. However, this is contraindicated in those patients who are impacted as this might cause bloating and faecal overflow. Indications for laxatives:
A bulk-forming laxative and a stimulant laxative, used individually or in combination, are effective for most clinical situations (Passmore et al.). Faecal impaction generally requires the use of laxative suppositories or enemas. It is important that Co-danthramer is discussed with Floella and that this drug is only prescribed for terminally ill patients. The carcinogenic risks of this preparation need to be highlighted, as well as the need for it to be prescribed in consultation with a physician. If a laxative is prescribed, the following needs to be described to Floella:
Ethics The GP responsible for writing the prescription for Co-danthramer for Floellas husband has a responsibility to ensure that the prescription is used in accordance with the preparations instructions. The nurse should report back to the GP informing him of the situation. It is important that both Floella and her husband understand why Floella should not take this drug. Team work
Evaluating effectiveness Follow up by appropriate professional
References Derrett C. Clinical diagnosis and management for the nurse prescriber. In: Courtenay M (ed.), Current Issues in Nurse Prescribing. London: Greenwich Medical Media, 2001: pp. 5558 Passmore AP, Wilson-Davies K, Stoker C, Scott ME. Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination. British Medical Journal 1993; 307: 769771 In the archive of Case Studies:
Let us know your views on this case study by accessing the feedback section. |
|||||||||||||||
| ____________________________________________________________________ | |
| Register | News | Education | Journals | Products | Links | Forum | Feedback | |
| published & managed by: Greenwich Medical Media Ltd |